Luban is a pharmaceutical company that develops fine chemicals and chiral products.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 22, 2017 | Post-IPO Equity | ¥37.60M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Hubei Gaotou Technology Financial Investment Management | — | Post-IPO Equity |
Gaorong Venture Capital | — | Post-IPO Equity |